Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H21ClN4O |
InChIKeyBYOIUNBCBSEBDN-BTTYYORXSA-N |
CAS Registry145335-62-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable Bowel Syndrome | Phase 2 | US | - | |
Irritable Bowel Syndrome | Preclinical | - | - | |
Nausea and vomiting | Preclinical | US | - | |
Nausea | Discovery | - | - |